both EMD and IHL are biotech companies, the only way to be successful in biotech is to get FDA approval, to do that a company must go through phase 1,2 and 3.
did EMD contact FDA at all ? what are the conditions EMD are targeting? at what stage trials are ? answers to these questions are the reason why the current IHL market cap is 5 times EMD. was there any company that got an FDA approval based on real world data ? IHL strategy is the closest to GW pharma the only success story so far globally.
IHL Price at posting:
55.0¢ Sentiment: Hold Disclosure: Held